An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Invacare Corporation to Present at the 12th Annual East Coast IDEAS Investor Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Invacare Corporation (NYSE: IVC) announced that CEO Matt Monaghan will present at the 12th Annual East Coast IDEAS Investor Conference on June 22, 2022. The presentation will be available via webcast at this link and can be replayed for 90 days. Alongside Monaghan, CFO Kathy Leneghan and director Lois Lee will conduct one-on-one meetings with interested investors. An updated investor presentation will be posted on the company’s website at this link.
Positive
None.
Negative
None.
ELYRIA, Ohio--(BUSINESS WIRE)--
Invacare Corporation (NYSE: IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced that Matt Monaghan, chairman, president and chief executive officer, will present at the 12th Annual East Coast IDEAS Investor Conference on Wednesday, June 22, 2022. The webcast of the presentation will be available at https://wsw.com/webcast/threepa37/ivc/ and it will be accessible for replay for 90 days following the conference.
The company’s management team, including Mr. Monaghan; Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director of treasury, investor relations and corporate communications, will be available for 1x1 meetings with interested investors.
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare's website at www.invacare.com.
